Cure Today

Adriamycin for Hodgkin Lymphoma May Increase Breast Cancer Risk

Treatment of Adriamycin, a type of chemotherapy, may be linked with breast cancer in Hodgkin lymphoma survivors, a study showed. Survivors of Hodgkin lymphoma who have received Adriamycin (doxorubicin ...
Nature

Cardiac abnormalities 15 years and more after adriamycin therapy in 229 childhood survivors of a solid tumour at the Institut Gustave Roussy

Despite strong evidence for the cardiac toxicity (Von Hoff et al, 1979; Grenier and Lipshultz, 1998) of anthracyclines, they continue to be among the most frequently used cytotoxic agents in adult and ...
Nature

Block sequential adriamycin CMF – optimal non-myeloablative chemotherapy for high risk adjuvant breast cancer?

After the publication of the 10-year survival data from Milan on the adjuvant use of the block sequential regimen consisting of four cycles of adriamycin followed by eight cycles of intravenous CMF, ...
Medindia

Adriamycin (50 mg) (Doxorubicin) Drug Price and Information

Doxorubicin (Adriamycin (50 mg)) is a cytotoxic anthracycline antibiotic, prescribed for treating various types of cancer.It works by killing cancer cells. The information provided on this page is ...
ascopubs.org

Second-line treatment with a combination of 5-fluorouracil, adriamycin, and mitomycin-C (FAM) in gemcitabine-pretreated pancreatic and biliary tract cancer

Predictive value of circulating VEGF in patients with advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma treated with cetuximab in combination with cisplatin and docetaxel (Italian ...
ascopubs.org

Gemcitabine/paclitaxel/adriamycin (GTA) as a nephron-sparing regimen in urothelial carcinoma: The MD Anderson Cancer Center (MDACC) experience.

Baseline geriatric 8 (G8) screening tool to predict overall survival in metastatic urothelial carcinoma treated with immune checkpoint inhibitors. Effect of body mass index (BMI) on efficacy of immune ...